Evidence map›Paper›PMID 33138653›Full record

ArticleAnnals of medicine2021

Disparities in case frequency and mortality of coronavirus disease 2019 (COVID-19) among various states in the United States.

Rohit S Loomba, Gaurav Aggarwal, Saurabh Aggarwal, Saul Flores, Enrique G Villarreal, Juan S Farias, Carl J Lavie

Abstract readComparative Study
In one paragraph

Article in Annals of medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Imaging of COVID-19.Seminars in roentgenology · 2022
    Article
  15. Article
  16. Article
  17. COVID-19 in Pediatrics.Rheumatic diseases clinics of North America · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rohit S LoombaAdvocate Children's Hospital, Chicago, IL, USA.ORCID 0000-0002-9116-2835
Gaurav AggarwalJersey City Medical Center, Jersey City, NJ, USA.
Saurabh AggarwalUnityPoint Health, Des Moines, IA, USA.
Saul FloresTexas Children's Hospital, Houston, TX, USA.ORCID 0000-0002-6274-5775
Enrique G VillarrealTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico.ORCID 0000-0001-8993-5192
Juan S FariasTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico.
Carl J LavieOchsner Medical Center, New Orleans, LA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo utilize publicly reported, state-level data to identify factors associated with the frequency of cases, tests, and mortality in the USA. MATERIALS AND

methodsRetrospective study using publicly reported data collected included the number of COVID-19 cases, tests and mortality from March 14th through April 30th. Publicly available state-level data was collected which included: demographics comorbidities, state characteristics and environmental factors. Univariate and multivariate regression analyses were performed to identify the significantly associated factors with percent mortality, case and testing frequency. All analyses were state-level analyses and not patient-level analyses.

resultsA total of 1,090,500 COVID-19 cases were reported during the study period. The calculated case and testing frequency were 3332 and 19,193 per 1,000,000 patients. There were 63,642 deaths during this period which resulted in a mortality of 5.8%. Factors including to but not limited to population density (beta coefficient 7.5,

conclusionsThere were wide variations in testing and case frequencies of COVID-19 among different states in the US. States with higher population density had a higher case and testing rate. States with larger population of elderly and higher tourism had a higher mortality. Key messages There were wide variations in testing and case frequencies of COVID-19 among different states in the USA. States with higher population density had a higher case and testing rate. States with larger population of elderly and higher tourism had a higher mortality.

Indexed as

Clinical Laboratory TechniquesComorbidityCoronavirus InfectionsCOVID-19COVID-19 TestingFemaleHealthcare DisparitiesHumansMalePandemicsPneumonia, ViralUnited StatesclimatecoronavirusCOVID-19epidemiologyrisk factors

Identifiers

PMID33138653
PMCPMC7877922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.